Want to join the conversation?
$ROP 2Q15 Call: Organic revenue in Medical was up at 2%, but if you adjust it for rugged mobile discontinuance, organic revenue would have been higher. FX was a 3% headwind in quarter for Medical, but overall revenue grew at 13%, operating profit was up 18%, & operating margin was 36.6%. We had double digit growth in our Medical device businesses.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.